Results 161 to 170 of about 52,937 (227)

Randomized controlled trial of emotion regulation therapy versus cognitive behavioral therapy to address distress in cancer caregivers. [PDF]

Ann Behav Med
Applebaum AJ, Jacobs JM, Fresco DM, Hoyt MA, Schofield E, Loschiavo MJ, O'Toole MS, Dunderdale LE, Mennin DS.   +8 more
europepmc   +1 more source

New dosing schedules in pre-treated patients with metastatic colorectal cancer. [PDF]

J Gastrointest Oncol
Pfeiffer P, Tarpgaard LS.
europepmc   +1 more source

Enriching stabilizing mutations through automated analysis of molecular dynamics simulations using BoostMut. [PDF]

Protein Sci
Korbeld KT, Fürst MJLJ.
europepmc   +1 more source

Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study. [PDF]

ESMO Gastrointest Oncol
Garcia-Carbonero R, Elez E, García-Alfonso P, Cubillo Gracían A, López López R, Jimenez-Fonseca P, Limón Mirón ML, Dasari A, Lonardi S, Zhu H, Chen L, Yang Z, Schelman WR, Tabernero J.   +13 more
europepmc   +1 more source

Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. [PDF]

JAAD Case Rep
Concannon HR, Ku RG, Brazel M, Selim MA, Fresco A.   +4 more
europepmc   +1 more source

Refractory microsatellite-stable metastatic colorectal cancer: a comparison between botensilimab + balstilimab and current standard of care. [PDF]

Immunooncol Technol
Bengala E, Santini D, Picone V.
europepmc   +1 more source

Visual attention in bilingual instructional videos: effects of audiovisual congruency and subtitle language. [PDF]

Cogn Res Princ Implic
Romero-Ortells I, Perea M, Gutierrez-Sigut E, Duñabeitia JA.   +3 more
europepmc   +1 more source

FRESCO-2 trial and fruquintinib: A clearer picture of the control arm. [PDF]

Transl Oncol
Ranganathan S, Haslam A, Olivier T, Prasad V.   +3 more
europepmc   +1 more source

The Early Movers Clinician's Guide: Co-Designing a Resource for the 24-Hour Movement Guidelines in Paediatric Occupational Therapy. [PDF]

Child Care Health Dev
Taylor LG, Phillips SM, Tzvetkov D, Alvarez L, Tucker P.   +4 more
europepmc   +1 more source

What Does α-Syn-SAA-Negative Parkinson's Disease Reveal About the Proposed "Biological Definition" of Parkinson's Disease? [PDF]

Mov Disord
Espay AJ, Cardoso F, Frucht SJ, Imarisio A, Lees AJ.   +4 more
europepmc   +1 more source